|
Q3 FY2026
As of Apr 30, 2026
|
Q2 FY2026
As of Jan 31, 2026
|
Q1 FY2026
As of Oct 31, 2025
|
Q4 FY2025
As of Jul 31, 2025
|
Q3 FY2025
As of Apr 30, 2025
|
Q2 FY2025
As of Jan 31, 2025
|
Q1 FY2025
As of Oct 31, 2024
|
Q4 FY2024
As of Jul 31, 2024
|
Q3 FY2024
As of Apr 30, 2024
|
Q2 FY2024
As of Jan 31, 2024
|
Q1 FY2024
As of Oct 31, 2023
|
Q4 FY2023
As of Jul 31, 2023
|
Q3 FY2023
As of Apr 30, 2023
|
Q2 FY2023
As of Jan 31, 2023
|
Q1 FY2023
As of Oct 31, 2022
|
Q4 FY2022
As of Jul 31, 2022
|
Q3 FY2022
As of Apr 30, 2022
|
Q2 FY2022
As of Jan 31, 2022
|
Q1 FY2022
As of Oct 31, 2021
|
Q4 FY2021
As of Jul 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Receivables | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Non-current | ||||||||||||||||||||
| Mineral property interests | ||||||||||||||||||||
| Equipment | ||||||||||||||||||||
| Note receivable | ||||||||||||||||||||
| Deferred financing assset | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Current | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Deposit liability | ||||||||||||||||||||
| Loan payable | ||||||||||||||||||||
| Payable to related parties | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Non-current | ||||||||||||||||||||
| Loan payable | ||||||||||||||||||||
| Credit facility | ||||||||||||||||||||
| Derivative liability | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity | ||||||||||||||||||||
| Capital stock, $0.001 par value, 400,000,000 shares authorized; 127,543,837 shares issued and outstanding at April 30, 2026 | ||||||||||||||||||||
| Shares subscribed in advance | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Shares subscribed | ||||||||||||||||||||
| Cumulative translation adjustment | ||||||||||||||||||||
| Deficit | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
